PharmaBoardroom

TJ Deng – GM China & Ian Wisenberg – CFO,…

TJ Deng, GM China and BioDuro Discovery; and Ian Wisenberg, CFO of BioDuro, share the strategic rationale behind Advent International’s 2019…

Chengbin Wu – CEO, EpimAb Biotherapeutics, China

Dr Chengbin Wu, founder and CEO of EpimAb Biotherapeutics, introduces their exciting and proprietary bispecific antibody-generating platform,…

Frédéric Cren – Chairman, CEO & Co-Founder,…

Inventiva is a French clinical-stage biotech company focused on developing oral small molecule epigenetic modulators in therapeutic areas with high…

The Medical Cannabis Investment Landscape

David H. Crean, managing director for Objective Capital Partners, highlights the progress that has been made over the past year in investments in…

Jean-Jacques Garaud – CEO, Inotrem, France

Inotrem is a French biotech company developing a novel approach to target inflammatory diseases based on the TREM-1 pathway. Its CEO, Dr Jean-Jacques…

Marc Comas – Managing Director, Accord Healthcare Iberia

Marc Comas, managing director of Accord Healthcare Iberia, highlights the footprint of the company as the leading generics and biosimilars player in…

Philippe Archinard – CEO, Transgene, France

Phillipe Archinard CEO of Transgene shares insights on the latest technologies being developed by the gene therapy specialist, explains how France’s…

Transitioning Pharma’s Data Supply Chain into the 21st Century

An examination of the evolution of the pharma data supply chain and the vital importance of establishing trust with patients to access complete…

Richie Etwaru – Human Data Ethicist & CEO,…

These insights come from Richie Etwaru, the CEO of Hu-Manity.co, known for pursuing the 31st Human Right “everyone has the right to legal ownership…

William (Wei) Cao – Founder, Chairman & CEO, Gracell,…

William Wei Cao, chairman and CEO of Gracell, shares the fascinating journey that inspired him to establish Gracell in Shanghai to tackle the four big…

Jin Woo Lee – Founder & CEO, YD Global Life Science,…

YD Global Life Science is a Korean biopharmaceutical company with ambitions to become a global leader in new drug development with USD 1 billion in…

Christine Placet – CEO, Horama, France

Christine Placet, CEO of French biotech Horama, discusses the objective of becoming one of the key players in the field of ophthalmic gene therapy.…

Tagged with BI